Psoriatic arthritis trials in China

In China 12 Also abroad 116

12 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Where
Beijing, Chongqing, Nanjing, Suzhou
Age
1 year to 18 years
People
190 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT03773965
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Beijing, Changzhou, Hangzhou, Shanghai, Shenyang
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 3Taking people
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Where
Beijing, Changchun, Chongqing, Guangzhou, Hangzhou, Nanjing, Shanghai
Age
5 years to 17 years
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Baotou Shi, Beijing, Bengbu, Chengdu, Guangzhou, Linyi Shi, Pingxiang, Taiyuan, Wuhan, Zhuzhou
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 2Taking people
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Where
Baoding, Beijing, Bozhou, Cangzhou, Changchun, Changsha, Chongqing, Dalian, Deyang, Dongguan, Guangzhou, Guiyang, Hangzhou, Jiangmen, Jinan, Kaifeng, Linfen, Luoyang, Luzhou, Nanchang, Nanchong, Nanjing, Nanning, Ningbo, Pingxiang, Puyang, Shanghai, Shaoyang, Shenyang, Shenzhen, Suzhou, Tianjin, Ürümqi, Weifang, Yancheng, Zhengzhou, Zhuzhou
Age
18 years to 70 years
People
156
Run by
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07406035
No phaseEnrolling by invitation
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
Where
Beijing
Age
18 years and over
People
500
Run by
Peking University People's Hospital
See details and how to joinNCT07188285
Phase 2Taking people
A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
Where
Chengdu
Age
18 years to 70 years
People
222
Run by
InventisBio Co., Ltd
See details and how to joinNCT07315061
Phase 2/3Taking people
A Study of Picankibart in Patients With Active Psoriatic Arthritis
Where
Hangzhou
Age
18 years to 75 years
People
222
Run by
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07295509
No phaseEnrolling by invitation
A Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis
Where
Fuzhou
Age
18 years and over
People
150
Run by
Chao Ji
See details and how to joinNCT06686082
No phaseNot yet taking people in China
Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
Where
Hunan
Age
18 years and over
People
1,000
Run by
Chongqing Genrix Biopharmaceutical Co., Ltd
See details and how to joinNCT06802848
No phaseNot yet taking people in China
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Where
Hangzhou
Age
18 years and over
People
10,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06766552
No phaseTaking people
Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Where
Nanjing
Age
18 years and over
People
400
Run by
Nanjing Medical University
See details and how to joinNCT06730334